Literature DB >> 31208690

Pilot Randomized Trial of a Self-Help Behavioral Activation Mobile App for Utilization in Primary Care.

Jennifer Dahne1, C W Lejuez2, Vanessa A Diaz3, Marty S Player3, Jacob Kustanowitz4, Julia W Felton5, Matthew J Carpenter3.   

Abstract

Mobile technologies can be leveraged to meet the need for evidence-based psychological depression treatment via primary care. The purpose of the present study was to preliminarily examine the feasibility and efficacy of a self-help brief behavioral activation mobile application (app; "Moodivate") for depressive symptoms among adults treated via primary care. Participants (N = 52) were recruited from primary care practices between January and December 2017 and were randomized 2:2:1 to receive (a) Moodivate, (b) an active control cognitive-behavioral therapy-based mobile app ("MoodKit"), or (c) treatment as usual (TAU; no app). Participants completed assessments of depressive symptoms weekly for 8 weeks. App analytics data were captured to examine Moodivate feasibility (analytics unavailable for control app). Moodivate participants on average had 46.76 (SD = 30.10) app sessions throughout the trial duration, spent 3.50 (2.76) minutes using the app per session, and spent 120.76 (101.02) minutes using the app in total throughout the trial. Nearly 70% of Moodivate participants continued to use the app 1 month after trial enrollment and 50% at the end of the 8-week follow-up period. A generalized estimating equation model examining change in depressive symptoms over time by treatment condition indicated a significant interaction between time and treatment condition (χ2 = 42.21, df = 14, p < .001). As compared to TAU, participants in both app conditions evidenced significant decreases in depressive symptoms over time, and these treatment gains were sustained across the trial period. These results preliminarily indicate feasibility of Moodivate as well as efficacy of both Moodivate and MoodKit for the treatment of depression among adults recruited via primary care. Future studies should focus on larger-scale examinations of treatment efficacy and effectiveness across primary care settings.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  depression; mobile health; primary care

Mesh:

Year:  2018        PMID: 31208690      PMCID: PMC6582985          DOI: 10.1016/j.beth.2018.12.003

Source DB:  PubMed          Journal:  Behav Ther        ISSN: 0005-7894


  36 in total

1.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  County-level estimates of mental health professional shortage in the United States.

Authors:  Kathleen C Thomas; Alan R Ellis; Thomas R Konrad; Charles E Holzer; Joseph P Morrissey
Journal:  Psychiatr Serv       Date:  2009-10       Impact factor: 3.084

4.  Integration of the brief behavioral activation treatment for depression (BATD) into a college orientation program: depression and alcohol outcomes.

Authors:  Elizabeth K Reynolds; Laura Macpherson; Matthew T Tull; David E Baruch; C W Lejuez
Journal:  J Couns Psychol       Date:  2011-10

5.  Behavioral activation and therapeutic exposure: an investigation of relative symptom changes in PTSD and depression during the course of integrated behavioral activation, situational exposure, and imaginal exposure techniques.

Authors:  Daniel F Gros; Matthew Price; Martha Strachan; Erica K Yuen; Melissa E Milanak; Ron Acierno
Journal:  Behav Modif       Date:  2012-06-07

6.  Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms.

Authors:  Laura MacPherson; Matthew T Tull; Alexis K Matusiewicz; Samantha Rodman; David R Strong; Christopher W Kahler; Derek R Hopko; Michael J Zvolensky; Richard A Brown; C W Lejuez
Journal:  J Consult Clin Psychol       Date:  2010-02

7.  Strategies for mHealth research: lessons from 3 mobile intervention studies.

Authors:  Dror Ben-Zeev; Stephen M Schueller; Mark Begale; Jennifer Duffecy; John M Kane; David C Mohr
Journal:  Adm Policy Ment Health       Date:  2015-03

8.  Minor depression: risk profiles, functional disability, health care use and risk of developing major depression.

Authors:  Pim Cuijpers; Ron de Graaf; Saskia van Dorsselaer
Journal:  J Affect Disord       Date:  2004-04       Impact factor: 4.839

9.  The PHQ-8 as a measure of current depression in the general population.

Authors:  Kurt Kroenke; Tara W Strine; Robert L Spitzer; Janet B W Williams; Joyce T Berry; Ali H Mokdad
Journal:  J Affect Disord       Date:  2008-08-27       Impact factor: 4.839

10.  Treatment of Adult Depression in the United States.

Authors:  Mark Olfson; Carlos Blanco; Steven C Marcus
Journal:  JAMA Intern Med       Date:  2016-10-01       Impact factor: 21.873

View more
  16 in total

1.  Development of an Emotion-Sensitive mHealth Approach for Mood-State Recognition in Bipolar Disorder.

Authors:  Henning Daus; Timon Bloecher; Ronny Egeler; Richard De Klerk; Wilhelm Stork; Matthias Backenstrass
Journal:  JMIR Ment Health       Date:  2020-07-03

2.  Leveraging health system telehealth and informatics infrastructure to create a continuum of services for COVID-19 screening, testing, and treatment.

Authors:  Dee Ford; Jillian B Harvey; James McElligott; Kathryn King; Kit N Simpson; Shawn Valenta; Emily H Warr; Tasia Walsh; Ellen Debenham; Carla Teasdale; Stephane Meystre; Jihad S Obeid; Christopher Metts; Leslie A Lenert
Journal:  J Am Med Inform Assoc       Date:  2020-12-09       Impact factor: 4.497

3.  A Behavioral Activation Mobile Health App for Smokers With Depression: Development and Pilot Evaluation in a Single-Arm Trial.

Authors:  Jaimee L Heffner; Noreen L Watson; Edit Serfozo; Kristin E Mull; Laura MacPherson; Melissa Gasser; Jonathan B Bricker
Journal:  JMIR Form Res       Date:  2019-11-27

Review 4.  Smartphone apps for depression and anxiety: a systematic review and meta-analysis of techniques to increase engagement.

Authors:  Ashley Wu; Matthew A Scult; Emily D Barnes; Jessica A Betancourt; Avital Falk; Faith M Gunning
Journal:  NPJ Digit Med       Date:  2021-02-11

Review 5.  Effectiveness of Smartphone-Based Cognitive Behavioral Therapy Among Patients With Major Depression: Systematic Review of Health Implications.

Authors:  Robert Hrynyschyn; Christoph Dockweiler
Journal:  JMIR Mhealth Uhealth       Date:  2021-02-10       Impact factor: 4.773

6.  Mental Health Intent Recognition for Arabic-Speaking Patients Using the Mini International Neuropsychiatric Interview (MINI) and BERT Model.

Authors:  Ridha Mezzi; Aymen Yahyaoui; Mohamed Wassim Krir; Wadii Boulila; Anis Koubaa
Journal:  Sensors (Basel)       Date:  2022-01-23       Impact factor: 3.576

Review 7.  Engagement with mobile health interventions for depression: A systematic review.

Authors:  Anthony Molloy; Page L Anderson
Journal:  Internet Interv       Date:  2021-09-11

8.  Toward Integration of mHealth in Primary Care in the Netherlands: A Qualitative Analysis of Stakeholder Perspectives.

Authors:  Esmee L S Bally; Tomris Cesuroglu
Journal:  Front Public Health       Date:  2020-01-15

9.  Scientific Publication Patterns of Mobile Technologies and Apps for Posttraumatic Stress Disorder Treatment: Bibliometric Co-Word Analysis.

Authors:  Atik Kulakli; Ivanna Shubina
Journal:  JMIR Mhealth Uhealth       Date:  2020-11-26       Impact factor: 4.773

Review 10.  Self-guided Cognitive Behavioral Therapy Apps for Depression: Systematic Assessment of Features, Functionality, and Congruence With Evidence.

Authors:  Laura Martinengo; Anne-Claire Stona; Konstadina Griva; Paola Dazzan; Carmine Maria Pariante; Florian von Wangenheim; Josip Car
Journal:  J Med Internet Res       Date:  2021-07-30       Impact factor: 7.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.